anonymous
Guest
anonymous
Guest
Don’t seems the Sanofi transformation is going swimmingly well. Not. As site level have previously warned the reductions are having a major impact on compliance. And the regulators have noticed. Multiple poor audits recently from different global regulators. I’m also hearing there might be a warning letter for one site …